anti-thymocyte globulin Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Indiana University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadtacrolimus

I am/have/hadnephrotoxicity

I am/have/hadproteinuria

I am/have/hadchronic disease

I am/have/hadorgan rejection

I am/have/hadrenal function

I am/have/hadrenal injury

I am/have/haddiabetes

I am/have/hadrenal failure

I am/have/hadliver transplant

I am/have/hadhypertension

I am/have/hadrenal function test

I am/have/hadrenal impairment

I am/have/hadcancer

I am/have/hadnephropathy

I am/have/hadglomerular filtration rate

I am/have/hadacute renal failure

I am/have/hadrenal toxicity

I am/have/hadhepatitis c

I am/have/hadhepatitis b

added new label for I am/have/had

more

I am looking for

I am looking fortacrolimus

I am looking forantithymocyte globulin

I am looking foreverolimus

I am looking forrabbit atg

I am looking formycophenolic acid

I am looking forhepatitis b

I am looking formycophenolate mofetil

I am looking formycophenolate

I am looking foranti-thymocyte globulin

I am looking forimmunosuppressive agents

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Liver transplant patients receive potent induction immunosuppression in the form of rabbit anti thymocyte globulin. Investigators believe that in conjunction with this induction regimen, patients can be maintained on Everolimus monotherapy without the risk of rejection.

tacrolimus

nephrotoxicity

everolimus

proteinuria

chronic disease

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.